InvestorsHub Logo
Followers 68
Posts 820
Boards Moderated 0
Alias Born 03/19/2009

Re: None

Saturday, 04/04/2009 4:25:30 AM

Saturday, April 04, 2009 4:25:30 AM

Post# of 2463
REPR....price decline.....

It is kind of interesting to note that this past couple days of higher volume is somewhat similiar to what occurred exactly one year ago when the stock churned around 9-10 cents on relatively massive volume.

There could be any number of reasons for the decline. As was mentioned previously it could simply be a person needing to raise cash for personal reasons (taxes, health problems, new opportunities in other stocks, etc). All it takes in the microcap world is one dedicated seller with a good-sized position and you can get a pretty good decline started in a stock. Selling begets more selling.

It is always possible someone could be nervous about any changes that might occur regarding the Medicare policy that allows "exclusive" reimbursement for the Freedom60 pump. I don't know whether the revised policy has already been implemented or when it is expected to go into effect, but my understanding is that other infusion pumps (primarily CADD) will be permitted reimbursement comparable to what Freedom60 receives. I don't know to what extent the current policy has benefited Freedom60 in penetrating the market, but I think REPR's pump should still maintain a cost/performance advantage over the competition.

See items 7 and 8.....

http://www.ngsmedicare.com/ngsmedicare/dmemac/EducationandSupport/ToolsandMaterials/pdf/RegionBCouncilQuestionNov08.pdf

I still think the mention of the Freedom60 pump in ParinGenix's patent application is rather interesting. If nothing else, I think it acknowledges growing awareness/exposure of the Freedom60 brand in the medical industry......

http://www1.investorvillage.com/smbd.asp?mb=9059&mn=12&pt=msg&mid=6883170